nodes	percent_of_prediction	percent_of_DWPC	metapath
Equilin—HSD17B1—The canonical retinoid cycle in rods (twilight vision)—MYO7A—melanoma	0.184	0.189	CbGpPWpGaD
Equilin—HSD17B1—Steroid Biosynthesis—CYP17A1—melanoma	0.106	0.108	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of steroid hormones and vitamin D—CUBN—melanoma	0.0674	0.0691	CbGpPWpGaD
Equilin—HSD17B1—Diseases associated with visual transduction—MYO7A—melanoma	0.0572	0.0587	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of steroid hormones and vitamin D—CYP17A1—melanoma	0.0406	0.0417	CbGpPWpGaD
Equilin—HSD17B1—Diseases associated with visual transduction—AKR1B10—melanoma	0.0337	0.0346	CbGpPWpGaD
Equilin—SHBG—Nongenotropic Androgen signaling—MAP2K2—melanoma	0.0194	0.0199	CbGpPWpGaD
Equilin—SHBG—Nongenotropic Androgen signaling—RAC1—melanoma	0.0184	0.0188	CbGpPWpGaD
Equilin—SHBG—Nongenotropic Androgen signaling—MAP2K1—melanoma	0.0137	0.0141	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—ACER3—melanoma	0.0137	0.014	CbGpPWpGaD
Equilin—HSD17B1—Diseases associated with visual transduction—PRKCA—melanoma	0.0111	0.0114	CbGpPWpGaD
Equilin—SHBG—Nongenotropic Androgen signaling—MAPK3—melanoma	0.00877	0.009	CbGpPWpGaD
Equilin—SHBG—Nongenotropic Androgen signaling—MAPK1—melanoma	0.00835	0.00856	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.00828	0.00849	CbGpPWpGaD
Equilin—HSD17B1—Disease—MYO7A—melanoma	0.00727	0.00745	CbGpPWpGaD
Equilin—SHBG—Nongenotropic Androgen signaling—PIK3CA—melanoma	0.00724	0.00743	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.00691	0.00709	CbGpPWpGaD
Equilin—SHBG—Nongenotropic Androgen signaling—HRAS—melanoma	0.0067	0.00687	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.00646	0.00663	CbGpPWpGaD
Equilin—HSD17B1—Disease—HS3ST5—melanoma	0.00618	0.00634	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ACER3—melanoma	0.00608	0.00624	CbGpPWpGaD
Equilin—SHBG—Nongenotropic Androgen signaling—AKT1—melanoma	0.00592	0.00607	CbGpPWpGaD
Equilin—Estrone—CYP1B1—melanoma	0.00559	0.223	CrCbGaD
Equilin—HSD17B1—Metabolism—UGT2B10—melanoma	0.00557	0.00571	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.00549	0.00564	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HS3ST5—melanoma	0.00517	0.00531	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—DRAP1—melanoma	0.00509	0.00522	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MYO7A—melanoma	0.00509	0.00522	CbGpPWpGaD
Equilin—HSD17B1—Disease—CUL3—melanoma	0.0044	0.00452	CbGpPWpGaD
Equilin—HSD17B1—Disease—TRRAP—melanoma	0.0044	0.00452	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TAS2R60—melanoma	0.00433	0.00444	CbGpPWpGaD
Equilin—HSD17B1—Disease—AKR1B10—melanoma	0.00428	0.00439	CbGpPWpGaD
Equilin—Estradiol—CYP1B1—melanoma	0.00423	0.169	CrCbGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.00416	0.00427	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PLCB4—melanoma	0.00392	0.00402	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—FASN—melanoma	0.00385	0.00395	CbGpPWpGaD
Equilin—HSD17B1—Disease—LUM—melanoma	0.00382	0.00392	CbGpPWpGaD
Equilin—HSD17B1—Disease—HPSE—melanoma	0.00374	0.00384	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SLC6A11—melanoma	0.00369	0.00378	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIP4K2A—melanoma	0.00369	0.00378	CbGpPWpGaD
Equilin—HSD17B1—Disease—CUBN—melanoma	0.00367	0.00377	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—MTAP—melanoma	0.00359	0.00368	CbGpPWpGaD
Equilin—HSD17B1—Disease—CSPG4—melanoma	0.00355	0.00364	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.00351	0.0036	CbGpPWpGaD
Equilin—HSD17B1—Disease—RPS3—melanoma	0.00349	0.00358	CbGpPWpGaD
Equilin—HSD17B1—Disease—SKI—melanoma	0.00344	0.00353	CbGpPWpGaD
Equilin—Estriol—ABCB1—melanoma	0.00337	0.134	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—CXCL1—melanoma	0.00328	0.00336	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PLCB4—melanoma	0.00328	0.00336	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—LUM—melanoma	0.0032	0.00328	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PHGDH—melanoma	0.0032	0.00328	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HPSE—melanoma	0.00313	0.00322	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CUL3—melanoma	0.00308	0.00316	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TRRAP—melanoma	0.00308	0.00316	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CUBN—melanoma	0.00308	0.00316	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AKR1B10—melanoma	0.003	0.00308	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SDHD—melanoma	0.00297	0.00305	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CSPG4—melanoma	0.00297	0.00305	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—BSG—melanoma	0.00297	0.00305	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GPAM—melanoma	0.00288	0.00295	CbGpPWpGaD
Equilin—HSD17B1—Disease—HDAC6—melanoma	0.00284	0.00291	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—F2RL1—melanoma	0.00279	0.00286	CbGpPWpGaD
Equilin—Estropipate—ALB—melanoma	0.0027	0.108	CrCbGaD
Equilin—HSD17B1—Disease—NPPA—melanoma	0.00269	0.00276	CbGpPWpGaD
Equilin—HSD17B1—Disease—VCAN—melanoma	0.00262	0.00269	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GRM3—melanoma	0.00262	0.00269	CbGpPWpGaD
Equilin—HSD17B1—Disease—WNT5A—melanoma	0.0026	0.00267	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—KISS1—melanoma	0.00248	0.00255	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PLA2G6—melanoma	0.00245	0.00251	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SKI—melanoma	0.00241	0.00247	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CXCR1—melanoma	0.00241	0.00247	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MC1R—melanoma	0.00237	0.00243	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GRM1—melanoma	0.00227	0.00233	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCR7—melanoma	0.00227	0.00233	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SUFU—melanoma	0.00221	0.00227	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—VCAN—melanoma	0.0022	0.00225	CbGpPWpGaD
Equilin—HSD17B1—Disease—GAB2—melanoma	0.00209	0.00215	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	0.00208	0.00213	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—RHOB—melanoma	0.00207	0.00212	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—BCL2L11—melanoma	0.00207	0.00212	CbGpPWpGaD
Equilin—HSD17B1—Disease—FASN—melanoma	0.00205	0.0021	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PPARG—melanoma	0.00201	0.00206	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HDAC6—melanoma	0.00199	0.00204	CbGpPWpGaD
Equilin—HSD17B1—Disease—HDAC2—melanoma	0.00197	0.00202	CbGpPWpGaD
Equilin—HSD17B1—Disease—FOXO4—melanoma	0.00197	0.00202	CbGpPWpGaD
Equilin—HSD17B1—Disease—CXCR4—melanoma	0.00197	0.00202	CbGpPWpGaD
Equilin—HSD17B1—Disease—CD44—melanoma	0.00194	0.00199	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CXCR2—melanoma	0.00188	0.00193	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP17A1—melanoma	0.00185	0.0019	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—RAC2—melanoma	0.00185	0.0019	CbGpPWpGaD
Equilin—Ethinyl Estradiol—ABCB1—melanoma	0.00184	0.0733	CrCbGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	0.00183	0.00188	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—WNT5A—melanoma	0.00182	0.00187	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—VEGFC—melanoma	0.00182	0.00187	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—ALB—melanoma	0.00181	0.00185	CbGpPWpGaD
Equilin—HSD17B1—Disease—AKT3—melanoma	0.00179	0.00184	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GNA11—melanoma	0.00175	0.0018	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—FASN—melanoma	0.00171	0.00176	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SLC5A5—melanoma	0.00169	0.00173	CbGpPWpGaD
Equilin—Estrone—ALB—melanoma	0.00168	0.0669	CrCbGaD
Equilin—HSD17B1—Metabolism—CD44—melanoma	0.00163	0.00167	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GNAQ—melanoma	0.00163	0.00167	CbGpPWpGaD
Equilin—Conjugated Estrogens—ABCB1—melanoma	0.00161	0.064	CrCbGaD
Equilin—Estrone—ABCB1—melanoma	0.0016	0.0639	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—F2R—melanoma	0.0016	0.00164	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	0.00159	0.00164	CbGpPWpGaD
Equilin—HSD17B1—Disease—ERBB4—melanoma	0.00158	0.00163	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	0.00158	0.00162	CbGpPWpGaD
Equilin—HSD17B1—Disease—CDKN2B—melanoma	0.00157	0.00161	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP1B1—melanoma	0.00156	0.0016	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—EDNRB—melanoma	0.00155	0.00159	CbGpPWpGaD
Equilin—HSD17B1—Disease—CD86—melanoma	0.00152	0.00156	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PTK2B—melanoma	0.00151	0.00154	CbGpPWpGaD
Equilin—HSD17B1—Disease—FGF1—melanoma	0.00147	0.00151	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GNA11—melanoma	0.00146	0.0015	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GAB2—melanoma	0.00146	0.0015	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FLT1—melanoma	0.00146	0.0015	CbGpPWpGaD
Equilin—HSD17B1—Disease—PDGFRA—melanoma	0.00143	0.00146	CbGpPWpGaD
Equilin—HSD17B1—Disease—PRKCA—melanoma	0.00141	0.00145	CbGpPWpGaD
Equilin—HSD17B1—Disease—ERCC2—melanoma	0.0014	0.00144	CbGpPWpGaD
Equilin—HSD17B1—Disease—MAP2K2—melanoma	0.00138	0.00142	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PTEN—melanoma	0.00138	0.00141	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CXCR4—melanoma	0.00138	0.00141	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HDAC2—melanoma	0.00138	0.00141	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FOXO4—melanoma	0.00138	0.00141	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GNAQ—melanoma	0.00136	0.0014	CbGpPWpGaD
Equilin—HSD17B1—Disease—TERT—melanoma	0.00131	0.00135	CbGpPWpGaD
Equilin—HSD17B1—Disease—HLA-A—melanoma	0.00131	0.00135	CbGpPWpGaD
Equilin—HSD17B1—Disease—RAC1—melanoma	0.00131	0.00134	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ABCB1—melanoma	0.00129	0.00132	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SYK—melanoma	0.00128	0.00131	CbGpPWpGaD
Equilin—Estradiol—ALB—melanoma	0.00127	0.0507	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—AKT3—melanoma	0.00126	0.00129	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NGFR—melanoma	0.00126	0.00129	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ITGAV—melanoma	0.00126	0.00129	CbGpPWpGaD
Equilin—HSD17B1—Disease—HIF1A—melanoma	0.00126	0.00129	CbGpPWpGaD
Equilin—Estradiol—ABCB1—melanoma	0.00122	0.0484	CrCbGaD
Equilin—HSD17B1—Metabolism—PRKCA—melanoma	0.00118	0.00121	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ERCC2—melanoma	0.00117	0.0012	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SOCS1—melanoma	0.00116	0.00119	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—S100B—melanoma	0.00116	0.00119	CbGpPWpGaD
Equilin—HSD17B1—Disease—NOS2—melanoma	0.00114	0.00117	CbGpPWpGaD
Equilin—HSD17B1—Disease—NOTCH1—melanoma	0.00113	0.00116	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ERBB4—melanoma	0.00111	0.00114	CbGpPWpGaD
Equilin—HSD17B1—Disease—CD80—melanoma	0.00111	0.00114	CbGpPWpGaD
Equilin—HSD17B1—Disease—KIT—melanoma	0.00111	0.00113	CbGpPWpGaD
Equilin—HSD17B1—Disease—APC—melanoma	0.00111	0.00113	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CDKN2B—melanoma	0.0011	0.00113	CbGpPWpGaD
Equilin—HSD17B1—Disease—EGF—melanoma	0.00109	0.00112	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CD86—melanoma	0.00106	0.00109	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—EDN1—melanoma	0.00106	0.00108	CbGpPWpGaD
Equilin—HSD17B1—Disease—BRAF—melanoma	0.00104	0.00107	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FGF1—melanoma	0.00103	0.00106	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CSF2—melanoma	0.00103	0.00106	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—E2F1—melanoma	0.00101	0.00104	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PDGFRA—melanoma	0.000999	0.00103	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ITGB3—melanoma	0.000989	0.00101	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PRKCA—melanoma	0.000989	0.00101	CbGpPWpGaD
Equilin—HSD17B1—Disease—MAP2K1—melanoma	0.000979	0.001	CbGpPWpGaD
Equilin—HSD17B1—Disease—PIK3CD—melanoma	0.000973	0.000998	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	0.000972	0.000997	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SPP1—melanoma	0.00097	0.000995	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MAP2K2—melanoma	0.000967	0.000992	CbGpPWpGaD
Equilin—HSD17B1—Disease—FGF2—melanoma	0.000931	0.000955	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CG—melanoma	0.000927	0.000951	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TERT—melanoma	0.00092	0.000943	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—RAC1—melanoma	0.000917	0.000941	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PPARG—melanoma	0.000894	0.000917	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HIF1A—melanoma	0.00088	0.000902	CbGpPWpGaD
Equilin—HSD17B1—Disease—MDM2—melanoma	0.000871	0.000894	CbGpPWpGaD
Equilin—HSD17B1—Disease—ERBB2—melanoma	0.000859	0.000881	CbGpPWpGaD
Equilin—HSD17B1—Disease—PIK3CB—melanoma	0.000848	0.00087	CbGpPWpGaD
Equilin—HSD17B1—Disease—CD4—melanoma	0.000846	0.000868	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—KDR—melanoma	0.000841	0.000863	CbGpPWpGaD
Equilin—HSD17B1—Disease—PTGS2—melanoma	0.00084	0.000862	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CD—melanoma	0.000815	0.000836	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FN1—melanoma	0.00081	0.000831	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ALB—melanoma	0.000804	0.000825	CbGpPWpGaD
Equilin—HSD17B1—Disease—CDKN1B—melanoma	0.000796	0.000816	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NOTCH1—melanoma	0.000792	0.000813	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CD80—melanoma	0.000776	0.000796	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—KIT—melanoma	0.000775	0.000795	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—APC—melanoma	0.000775	0.000795	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CG—melanoma	0.000775	0.000795	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—EGF—melanoma	0.000766	0.000786	CbGpPWpGaD
Equilin—HSD17B1—Disease—CTNNB1—melanoma	0.000752	0.000771	CbGpPWpGaD
Equilin—HSD17B1—Disease—CDKN1A—melanoma	0.000734	0.000753	CbGpPWpGaD
Equilin—HSD17B1—Disease—PTEN—melanoma	0.000733	0.000751	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—BRAF—melanoma	0.000728	0.000747	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CB—melanoma	0.00071	0.000728	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IGF1—melanoma	0.000709	0.000728	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PTGS2—melanoma	0.000704	0.000722	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MAP2K1—melanoma	0.000686	0.000703	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CD—melanoma	0.000681	0.000699	CbGpPWpGaD
Equilin—HSD17B1—Disease—STAT3—melanoma	0.000655	0.000672	CbGpPWpGaD
Equilin—HSD17B1—Disease—NRAS—melanoma	0.000654	0.00067	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FGF2—melanoma	0.000652	0.000669	CbGpPWpGaD
Equilin—HSD17B1—Disease—MAPK3—melanoma	0.000626	0.000642	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PTEN—melanoma	0.000614	0.000629	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MDM2—melanoma	0.00061	0.000626	CbGpPWpGaD
Equilin—HSD17B1—Disease—MYC—melanoma	0.000609	0.000625	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ERBB2—melanoma	0.000602	0.000617	CbGpPWpGaD
Equilin—HSD17B1—Disease—MAPK1—melanoma	0.000596	0.000611	CbGpPWpGaD
Equilin—HSD17B1—Disease—EGFR—melanoma	0.000596	0.000611	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CB—melanoma	0.000594	0.000609	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CXCL8—melanoma	0.000571	0.000585	CbGpPWpGaD
Equilin—HSD17B1—Disease—KRAS—melanoma	0.000563	0.000577	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CDKN1B—melanoma	0.000557	0.000572	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CASP3—melanoma	0.000546	0.00056	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IL2—melanoma	0.000545	0.000559	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCND1—melanoma	0.000532	0.000545	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CTNNB1—melanoma	0.000526	0.00054	CbGpPWpGaD
Equilin—HSD17B1—Disease—PIK3CA—melanoma	0.000517	0.00053	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MMP9—melanoma	0.000516	0.000529	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CDKN1A—melanoma	0.000514	0.000527	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PTEN—melanoma	0.000513	0.000526	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NFKB1—melanoma	0.000511	0.000524	CbGpPWpGaD
Equilin—HSD17B1—Disease—HRAS—melanoma	0.000478	0.00049	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—VEGFA—melanoma	0.000463	0.000475	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—STAT3—melanoma	0.000459	0.000471	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NRAS—melanoma	0.000458	0.00047	CbGpPWpGaD
Equilin—HSD17B1—Disease—IL6—melanoma	0.000458	0.000469	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MAPK3—melanoma	0.000438	0.00045	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CA—melanoma	0.000433	0.000444	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MYC—melanoma	0.000426	0.000437	CbGpPWpGaD
Equilin—HSD17B1—Disease—AKT1—melanoma	0.000422	0.000433	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MAPK1—melanoma	0.000417	0.000428	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—EGFR—melanoma	0.000417	0.000428	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—KRAS—melanoma	0.000394	0.000404	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CA—melanoma	0.000362	0.000371	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—AKT1—melanoma	0.000354	0.000363	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TP53—melanoma	0.00035	0.000359	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HRAS—melanoma	0.000335	0.000343	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IL6—melanoma	0.00032	0.000329	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AKT1—melanoma	0.000296	0.000303	CbGpPWpGaD
